Ποια είναι η τιμή για Nutra Pharma Corp. (NPHC)

Η τιμή για Nutra Pharma Corp. (NPHC) είναι $0.0001

Ποια είναι η κεφαλαιοποίηση αγοράς για Nutra Pharma Corp. (NPHC)

Η κεφαλαιοποίηση αγοράς για Nutra Pharma Corp. (NPHC) είναι $715.97K

Nutra Pharma Corp. (NPHC) Τιμή και Κεφαλαιοποίηση Αγοράς

Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.

Η τιμή για NPHC	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$763.93 $715.97K	NVDA	$5.470T	+763,930,631.75%
$623.92 $715.97K	AAPL	$4.467T	+623,916,053.72%
$582.99 $715.97K	GOOG	$4.174T	+582,985,891.00%
$516.79 $715.97K	MSFT	$3.700T	+516,789,961.85%
$398.67 $715.97K	AMZN	$2.854T	+398,666,148.52%

Η τιμή για NPHC

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$763.93 $715.97K